Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1975 Jun;37(6):640–646. doi: 10.1136/hrt.37.6.640

Phentolamine for vasodilator therapy in left ventricular failure complicating acute myocardial infarction. Haemodynamic study.

C l Perret, J P Gardaz, M Reynaert, F Grimbert, J F Enrico
PMCID: PMC482849  PMID: 1148063

Abstract

In 15 patients with acute myocardial infarction associated with signs of left ventricular dysfunction, phentolamine was infused intravenously in a dose of 10 mg per hour. This therapy induced a substantial reduction in mean right atrial pressure from 10 to 7 mmHg (1.3 to 0.9 kPa) (P) less than 0.001), and in pulmonary capillary wedge pressure from 20 to 13 mmHg (2.7 to 1.7 kPa) (P less than 0.001). The cardiac index increased from 2.5 to 3.0 1/min per m-minus 2 (P less than 0.001) accompanied by a fall in both the systemic and pulmonary vascular resistances (P less than 0.001). On the other hand, the mean stroke work index did not change significantly after phentolamine, because of tar resistance. With the dose used the mean arterial pressure decreased from 112 to 99 mmHg (14.9 to 13.2 kPa) (P less than 0.001). No adverse effects attributable to the drug treatment were noted. Benefits of this treatment are probably related to reduction in the impedance of left ventricular ejection and possibly to its relaxant effect on the venous tone. The drug may also improve subendocardial perfusion by decreasing left diastolic ventricular pressure. This could possibly limit extension of necrosis. Thus vasodilator therapy appears to be of particular interest in left ventricular failure complicating acute myocardial infarction, where inotropic agents may be contraindicated.

Full text

PDF
640

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braunwald E. Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol. 1971 Apr;27(4):416–432. doi: 10.1016/0002-9149(71)90439-5. [DOI] [PubMed] [Google Scholar]
  2. Chatterjee K., Parmley W. W., Ganz W., Forrester J., Walinsky P., Crexells C., Swan H. J. Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation. 1973 Dec;48(6):1183–1193. doi: 10.1161/01.cir.48.6.1183. [DOI] [PubMed] [Google Scholar]
  3. Cohn J. N. Blood pressure and cardiac performance. Am J Med. 1973 Sep;55(3):351–361. doi: 10.1016/0002-9343(73)90135-6. [DOI] [PubMed] [Google Scholar]
  4. Cohn J. N., Tristani F. E., Khatri I. M. Cardiac and peripheral vascular effects of digitalis in clinical cardiogenic shock. Am Heart J. 1969 Sep;78(3):318–330. doi: 10.1016/0002-8703(69)90039-8. [DOI] [PubMed] [Google Scholar]
  5. Dikshit K., Vyden J. K., Forrester J. S., Chatterjee K., Prakash R., Swan H. J. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med. 1973 May 24;288(21):1087–1090. doi: 10.1056/NEJM197305242882102. [DOI] [PubMed] [Google Scholar]
  6. Franciosa J. A., Limas C. J., Guiha N. H., Rodriguera E., Cohn J. N. Improved left ventricular function during nitroprusside infusion in acute myocardial infarction. Lancet. 1972 Mar 25;1(7752):650–654. doi: 10.1016/s0140-6736(72)90460-6. [DOI] [PubMed] [Google Scholar]
  7. Hodges M., Friesinger G. C., Riggins R. C., Dagenais G. R. Effects of intravenously administered digoxin on mild left ventricular failure in acute myocardial infarction in man. Am J Cardiol. 1972 Jun;29(6):749–756. doi: 10.1016/0002-9149(72)90492-4. [DOI] [PubMed] [Google Scholar]
  8. Kelly D. T., Delgado C. E., Taylor D. R., Pitt B., Ross R. S. Use of phentolamine in acute myocardial infarction associated with hypertension and left ventricular failure. Circulation. 1973 Apr;47(4):729–735. doi: 10.1161/01.cir.47.4.729. [DOI] [PubMed] [Google Scholar]
  9. Majid P. A., Sharma B., Taylor S. H. Phentolamine for vasodilator treatment of severe heart-failure. Lancet. 1971 Oct 2;2(7727):719–724. doi: 10.1016/s0140-6736(71)92098-8. [DOI] [PubMed] [Google Scholar]
  10. Malmcrona R., Schröder G., Werkö L. Haemodynamic effects of digitalis in acute myocardial infarction. Acta Med Scand. 1966 Jul;180(1):55–63. doi: 10.1111/j.0954-6820.1966.tb02808.x. [DOI] [PubMed] [Google Scholar]
  11. Maroko P. R., Braunwald E. Modification of myocardial infarction size after coronary occlusion. Ann Intern Med. 1973 Nov;79(5):720–733. doi: 10.7326/0003-4819-79-5-720. [DOI] [PubMed] [Google Scholar]
  12. RAAB W., VAN LITH P., LEPESCHKIN E., HERRLICH H. C. Catecholamine-induced myocardial hypoxia in the presence of impaired coronary dilatability independent of external cardiac work. Am J Cardiol. 1962 Mar;9:455–470. doi: 10.1016/0002-9149(62)90163-7. [DOI] [PubMed] [Google Scholar]
  13. ROSS J., Jr, BRAUNWALD E. THE STUDY OF LEFT VENTRICULAR FUNCTION IN MAN BY INCREASING RESISTANCE TO VENTRICULAR EJECTION WITH ANGIOTENSIN. Circulation. 1964 May;29:739–749. doi: 10.1161/01.cir.29.5.739. [DOI] [PubMed] [Google Scholar]
  14. Rahimtoola S. H., Sinno M. Z., Chuquimia R., Loeb H. S., Rosen K. M., Gunnar R. M. Effects of ouabain on impaired left ventricular function in acute myocardial infarction. N Engl J Med. 1972 Sep 14;287(11):527–531. doi: 10.1056/NEJM197209142871102. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES